What does the evidence say about Green Tea Cognition Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Green Tea Cognition Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - For risk of bias assessment, the Cochrane Risk of Bias Tool (version 2.0) was used. [Mátyus RO (2025); evidence level 1] - Background: Green tea ( Camellia sinensis ) has been consumed for centuries, and its beneficial effects on human health have been studied in recent decades. [Mátyus RO (2025); evidence level 1] - l-theanine, an active ingredient in green tea, has been used to improve cognition and mood. [Mátyus RO (2025); evidence level 1] - This study consolidates the evidence based on phytochemicals for cognitive enhancement, highlighting a need for more robust, methodologically sound trials to determine if these natural compounds hold promise in cognitive therapeutics, particularly for populations with cognitive impairments. [Marsh Alexander (2026); evidence level 3] - Accordingly, this review prespecified phytochemicals that meet 3 criteria: long-standing traditional association with cognition, biological plausibility supported by preclinical evidence, and progression into human research or commercial cognitive-health formulations, includingL. [Marsh Alexander (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.